Decision regret after external beam radiotherapy and high dose-rate brachytherapy boost for prostate cancer

1

Localized prostate cancer is the most common cancer diagnosis among men in Western countries, with various treatment options available.
2

Decision regret is a prevalent issue among cancer patients, with approximately 57% reporting some level of regret after radiotherapy.
3

The study aimed to analyze decision regret specifically after external beam radiotherapy combined with high dose-rate brachytherapy for prostate cancer.
4

Patient-reported outcomes were assessed using validated questionnaires, including the Decision Regret Scale and the Expanded Prostate Cancer Indec Composite.
5

Determinants of decision regret included health-related quality of life, shared decision-making, and treatment outcomes.

World Journal Of Urology

by Lars Haack, David Krug, Severin Rodler, Philipp Nuhn, Christof van der Horst, Christian Schulz, Olaf Wittenstein, Claudia Schmalz, Oliver Blanck, Frank-André Siebert, Alexander Fabian
April 9, 2025

1